Myriad Genetics (MYGN) Tops Q1 EPS by 15c, Revenues Beat

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 10/22/2026

1. SPCX
2. NVDA
3. NFLX
4. META
5. TSLA
6. ISRG
7. SMCI
8. RTX
9. S
10. COF

Go back to Myriad Genetics (MYGN) Tops Q1 EPS by 15c, Revenues Beat

Myriad Genetics Delivers 56% Sequential Increase in Quarterly Revenue; Test Volumes Reach 90% of Pre-COVID-19 Level at End of Quarter

November 9, 2020 8:00 AM EST

Highlights:

Revenue of $145.2 million up 56% sequentially in quarter ended Sept. 30, 2020GAAP operating income increased $28.7 million sequentially; non-GAAP operating income increased $30.2 million sequentiallyGAAP EPS of ($0.20) and adjusted EPS of ($0.15) improved sequentially$40 million in annualized cost... More